Peelaerts, Wouter, et al. “Inhibiting the Mitochondrial Pyruvate Carrier Does Not Ameliorate Synucleinopathy in the Absence of Inflammation or Metabolic Deficits”. Free Neuropathology, vol. 1, Nov. 2020, p. 33, doi:10.17879/freeneuropathology-2020-3049.